Protamine-sulfate

  • PDF / 169,012 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 25 Downloads / 175 Views

DOWNLOAD

REPORT


1 S

Stent thrombosis: case report. In a retrospective study including 472 patients, a patient [age and sex not stated] was described, who developed stent thrombosis during treatment with protamine sulfate to prevent bleeding after percutaneous coronary interventions (PCI). The patient underwent elective PCI due to a non-acute myocardial infarction lesion and immediately IV protamine sulfate [protamine; dosage not stated] injection was administered for bleeding prophylaxis. After 24 days of zotarolimus-eluting stent implantation, a definite stent thrombosis developed [outcome not stated]. Kubota M, et al. Mid-term Clinical Outcomes of Immediate Protamine Use Following Elective Percutaneous Coronary Interventions. International Heart Journal 61: 865-871, 803515319 No. 5, 29 Sep 2020. Available from: URL: http://doi.org/10.1536/ihj.20-126

0114-9954/20/1830-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 14 Nov 2020 No. 1830

Data Loading...